Net Cash Provided by (Used in) Operating Activities |
9.5M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
155M |
USD |
+47.6% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-181M |
USD |
-96.2% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
1.5K |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
1 |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-16.8M |
USD |
-76.8% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
24.3M |
USD |
+15.2% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
11.1M |
USD |
-14% |
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.22 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
2.56B |
USD |
+11.8% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
5.7M |
USD |
+54.1% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
35.9M |
USD |
-1.91% |
Dec 31, 2023 |
Q4 2023 |
Deferred Federal Income Tax Expense (Benefit) |
24.5M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
-19.6M |
USD |
-158% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
400K |
USD |
0% |
Dec 31, 2023 |
Q4 2023 |
Current State and Local Tax Expense (Benefit) |
400K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
-20M |
USD |
-163% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
84.9M |
USD |
+5.73% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
1.7M |
USD |
+1600% |
Dec 31, 2023 |
Q4 2023 |